To evaluate the clinical significance of DAPK promoter methylation in GC, we further determined whether DAPK promoter methylation was correlated with clinicopathological characteristics, including sex status, tumor stage, tumor histology, and lymph node status. This evidence concerns the gene DAPK1 and neoplasm.